Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia

BOSTON--(BUSINESS WIRE)--Nov. 29, 2023-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news